RecruitingPhase 3NCT07007312
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Sponsor: Kura Oncology, Inc.
Wheeling, WV · +43 more sites
1 recruiting leukemia studies with a site in Wheeling, WV.
Sponsor: Kura Oncology, Inc.
Wheeling, WV · +43 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.